A large number of trials have been conducted with Monimax. 27 different anticoccidial sensitivity tests (ASTs) conducted over a 7-year period were pooled and analysed. The results showed a significant reduction in all Eimeria species lesions and a significant improvement in all measured performance parameters compared to the infected by untreated control group.
- Change country
Multi-Study Analysis on the Efficacy of Nicarbazin / Monensin, a Novel Coccidiostat for Use in Broilers
Poster | 11.04.2022
Poster presented by Ben Dehaeck at ICPIH 2022, Cartagena, Colombia.
global presence
Local support from a global company
Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us
Huvepharma®
Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us
Change country
The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.
To view all products and services, select Global from the dropdown menu or click .
Change language
Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.
Europe
top
Your browser is out of date!
Update your browser to view this website correctly. Update my browser now